Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors

Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors

US Patent 10039753 · Granted Aug 7, 2018

Estimated economic value: $243,216,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Message referencing2025
Signaling parameter value information in a parameter set to reduce the amount of2025
Fused heterocycles as 5-HT2A receptor agonists2025
Rectangular tile group signaling2025
Combinations for treatment of NAFLD/NASH and related diseases2025
BCKDK inhibitors and/or degraders2025
BCKDK inhibitors and/or degraders2025
Fused heterocycles as 5-HT2A receptor agonists2025
Compounds and method of treating COVID-192025
Protoporphyrinogen oxidase inhibitors2025
Methods for antagonizing a melanocortin 4 receptor2025
Tricyclic compounds and their use as phosphodiesterase inhibitors2024